FindTrial
Sign In

A Comparative clinical trial to study the effects of modified mustadi yapana basti and bhadranimbadi asthapana basti in patients with prameha poorvarupa w.r.s pre-diabetes

A randomized comparative clinical trial study to evaluate the efficacy of modified Mustadi Yapana basti and Bhadranimbadi Asthapana basti in the management of Prameha Poorvarupa w.s.r to prediabetes - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082911
Enrollment
20
Registered
2025-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R730- Abnormal glucose

Interventions

None listed

Sponsors

Parul Ayurved Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of either gender between age group of 18 to 60. 2. Patients fulfilling the criteria of diagnosis according to american diabetes association (hbA1C - 5.7% - 6.4%) 3. Patients suitable for basti karma 4. Patients having BMI 22.2 kg/m2 - 29.9 kg/m2 ( according to WHO) 5. Patients willing to sign informed consent and able to participate in the study procedure.

Exclusion criteria

Exclusion criteria: 1. Known case of Diabetes Mellitus, Insulin Dependent Diabetes, Juvenile Diabetes Mellitus and Gestational Diabetes. 2. known case of Major Systemic Diseases like IHD, Malignancies, Uncontrolled Hypertension. 3. Patients on prolonged medication ( more than 6 weeks) with Corticosteroids or any other Drug that may have an influence on the outcome of the study. 4. Pregnant and lactating women. 5. Patients with active infective diseases like Tuberculosis, Hepatitis B. 6. Immunocompromised patients. 7. Patients not suitable for basti karma)

Design outcomes

Primary

MeasureTime frame
To normalize glycemic state and improve quality of life in prediabetic patientsTimepoint: 10 days of treatment and followup on the 16th day—

Secondary

MeasureTime frame
To study the efficacy of modified mustadi yapana basti & bhadranimbadi asthapana basti To compare the efficacy of modified mustadi yapana basti & bhadranimbadi asthapana basti Standardization of modified mustadi yapana basti & bhadranimbadi asthapana basti To assess the specific probiotic strains of lactobacillus in modified mustadi yapana basti & bhadranimbadi asthapana basti through microbiological analysis To study the role of modified mustadi yapana basti & modified bhadranimbadi asthapana basti in improving gut microbiota in pre-diabetes Timepoint: 8 days of treatment(basti chikitsa) & followup on 16th day—

Countries

India

Contacts

Public ContactDr Sangeeta H Toshikhane

Parul Institute of Ayurved

sangeeta.toshikhane26791@paruluniversity.ac.in9964596479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026